Abstract:OBJECTIVE:To observe that antiretroviral efficacy, immune reconstitution of four-year highly active antiretroviral therapy (HAART), and evaluate its side effect in Chinese HIV-1-infected patients.METHODS:A total of 258 HIV-1 infected patients, given HAART regimens composed of two nucleoside reverse transcriptase inhibitor (NRTI) and one non-nucleoside reverse transcriptase inhibitor (NNRTI) for mean 51.5 months, measured HIV RNA viral load (VL) and the counts of CD(4)(+) T cell, CD(8)(+) T cell at the baseline and 6, 12, 24, 36 and 48 months after HAART initiation, respectively, monitoring side effect, blood routine, main biochemical parameters, and other disadvantageous accidents during the 51.5-month treatment.RESULTS:Plasma HIV-1 RNA level was determined by fluorescent quantitative polymerase chain reactions (FQ-PCR) at the baseline and 6, 12, 24, 36 and 48 months after starting HAART, and showed 5.27, 2.97, 2.74, 2.62, 2.67 and 2.75 lg (copies/ml), respectively. The counts of CD(4)(+) T cell from (127 ± 63) cells/µl at the baseline increased to (190 ± 115), (248 ± 93), (269 ± 127), (296 ± 156) and (317 ± 195) cells/µl at 6, 12, 24, 36 and 48 months after starting HAART. A total of 149 treated patients (57.8%)had gastrointestinal side effects, peripheral polyneuropathy, various rashes, central nervous system disorders, fever or baldness. Twenty-two patients changed one of three medicines to another because toxicity. Sixteen changed the regimen to the second line HAART for lactic acidosis or other serious toxicities.CONCLUSIONS:A total of 258 HIV-1 infected Chinese patients treated with two NRTI and one NNRTI as first line HAART regimen during mean 51.5 months, showed a good antiretroviral efficacy and immune reconstitution, but a few side-effects at the parts of patients. It is necessary to treat adverse effect and change HAART regimen for severe toxicity in time.

Study on Quality of Life in AIDS Patients Receiving Short-Term Highly Active Antiretroviral Therapy(haart)

The Impact of Highly Active Antiretroviral Treatment on the Blood Profiles of Patients with Acquired Immune Deficiency Syndrome

Ouality of life in AIDS patients receiving HAART

Adherence to Highly Active Antiretroviral Therapy and Quality of Life in Patients with Acquired Immunedeficiency Syndrome

[Evaluation on the Highly Active Anti-Retroviral Therapy in 181 AIDS Patients].

The Effect Evaluation of Highly Active Antiretroviral Therapy to Patients with AIDS in Hubei Province of China

Analysis on the efficacy of highly active antiretroviral therapy in AIDS

[Study on the quality of life and influencing factors among people living with AIDS].

Study on factors associated with life quality of family members of people living with HIV/AIDS who are receiving highly active antiretroviral therapy

Two-year prospective cohort study on quality of life outcomes among people living with HIV after initiation of antiretroviral therapy in Guangxi, China.

Evalution of highly active antiretroviral therapy in 182 patients with HIV/AIDS

A Follow-up Survey on Mental Health of People with HIV/AIDS in the Early Stage of Antiviral Therapy

Study on Quality of Life among People Living with HIV/AIDS in Rural Areas in Shanxi Province

[Impact of Highly Active Antiretroviral Therapy on Plasma MCP-1 and MSP in AIDS Patients].

Meta-analysis of effect of AIDS patients on HAART in the short-term

Study on effect of quality of life intervention for patients with HIV infected /AIDS patients during follow-up period based on clinical nursing practice guide

[The Evaluation of Four-Year Highly Active Antiretroviral Therapy in HIV-1 Infected Patients].

The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.

Study on social support among AIDS patients received ART service in Anhui Province

Study on the hope level and its influence factors of patients with HIV/AIDS who received antiretroviral therapy

[Clinical Impacts of Highly Active Antiretroviral Therapy on Patients of Hemophilia Combined with Acquired Immunodeficiency Syndrome: 6-Year Follow-Up of 39 Cases].